Citi Starts Ovid Therapeutics Inc (OVID) at Buy
Tweet
Share
E-mailGet Alerts OVID Hot Sheet
Price: $2.80 -4.44%
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Citi initiates coverage on Ovid Therapeutics Inc (NASDAQ: OVID) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Ovid Therapeutics Inc click here. For more ratings news on Ovid Therapeutics Inc click here.
Shares of Ovid Therapeutics Inc closed at $14.48 Friday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Starts Clean Max Enviro Energy Solutions (CLEANMAX:IN) at Buy
- Nomura/Instinet Starts Lenskart Solutions (LENSKART:IN) at Buy
- Roth/MKM Starts CapsoVision Inc (CV) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
